Insights from 2024 ASCO® GU Annual Meeting

 

Insights from 2024 ASCO® GU Annual Meeting
P

ASCO® GU 2024 Insights: "JAVELIN Bladder 100 & US PATRIOT-II Studies - Avelumab 1L Maintenance for Advanced Urothelial Carcinoma"

By Insights from 2024 ASCO® GU Annual Meeting FEATURING Petros Grivas
By Insights from 2024 ASCO® GU Annual Meeting FEATURING Petros Grivas
0 views
February 6, 2024
Comments 0
Login to view comments. Click here to Login
Videos
09:54
Insights from 2024 ASCO® GU Annual Meeting

The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors

Feat. R. McKay
09:53
Insights from 2024 ASCO® GU Annual Meeting

Real-World Genomic Testing Patterns in Patients With Prostate Cancer

Feat. D. Kaakour
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
05:31
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Subgroup Analyses of Efficacy Outcomes…

Feat. V. Grünwald
10:56
Insights from 2024 ASCO® GU Annual Meeting

From CHAARTED Low- and High-Volume Disease to PSMA PET Imaging Volum…

Feat. L. Unterrainer
07:53
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Transperineal Versus Transrectal Prost…

Feat. J. Hu
19:02
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Underutilization of ADT Intensificatio…

Feat. P. Goebell
04:50
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Nivo + Cabozantinib vs. Sunitinib for …

Feat. M. Bourlon
07:53
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Subcutaneous vs. Intravenous Nivo for …

Feat. S. George
03:19
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Difference in High-Risk Prostate Cance…

Feat. S. Semko
04:14
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Patient-Provider Rurality and Outcomes…

Feat. A. Guha
20:40
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Role of Systemic Therapy for Node Posi…

Feat. M. Joshi
04:50
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Salvage RT for Local Recurrence of Pro…

Feat. A. Dal Pra
16:08
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Salvage Radiotherapy Options for Bioch…

Feat. A. Dal Pra
11:27
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "EMBARK Trial - Outcomes of Men With Hi…

Feat. N. Shore
05:48
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "UNITE Study - Outcomes in Patients Wit…

Feat. A. Nizam
06:55
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "HER2 and PD-L1 Immunohistochemistry Ex…

Feat. D. Aggen
09:03
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Long-Term Follow-Up Data From the Chec…

Feat. D. McDermott
12:39
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Prognostic Value of FDG, PSMA, and DOT…

Feat. F. Pouliot
26:15
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Update on Biomarkers in Renal Cell Car…

Feat. D. Braun
05:31
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "PSA Flare in Patients With mCRPC Under…

Feat. H. Li
09:59
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "PROMPT-2 Trial - PSA Response Among Pa…

Feat. G. Brown
14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
03:56
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "SPOTLIGHT Study - Impact of 18F-flotuf…

Feat. P. Twardowski
09:38
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Management of Non-ccRCC"

Feat. K. Beckermann
06:05
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Differences in Genomic, Transcriptomic…

Feat. U. Swami
06:26
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Radiographic Progression Without PSA P…

Feat. I. Davis
12:56
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Predicting Clinical Outcomes of Neoadj…

Feat. B. Faltas
05:07
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "TROPION‑PanTumor01 Study - Dato-DXd in…

Feat. A. Drakaki
10:29
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "AMBASSADOR Alliance A031501 Study of P…

Feat. A. Apolo
09:39
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "PemCab Trial - Cabozantinib + Pembro a…

Feat. R. Jain
06:21
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "JAVELIN Bladder 100 & US PATRIOT-I…

Feat. P. Grivas
14:00
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Ca…

Feat. G. Sonpavde
10:40
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Systemic Treatment of High-Risk Biochem…

Feat. C. Paller
05:46
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Adherence to ASCO® Language of Respect …

Feat. R. Barragán Carrillo
14:51
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Tailoring Prostate Cancer Care - EMBARK…

Feat. S. Freedland
11:21
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "CABATEN/GETNE-T1914 Trial - Cabo + Ate…

Feat. E. Grande
04:43
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Real-World Comparison of PSA Response …

Feat. B. Lowentritt
07:26
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Impact of Standard-of-Truth Method on …

Feat. B. Lowentritt